Guggenheim Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-28,129
| Closed | -$1.92M | – | 2044 |
|
|
2022
Q3 | $1.92M | Buy |
+28,129
| New | +$1.92M | 0.02% | 853 |
|
|
2021
Q4 | – | Sell |
-42,692
| Closed | -$1.09M | – | 2267 |
|
|
2021
Q3 | $1.09M | Buy |
42,692
+5,170
| +14% | +$132K | 0.01% | 1369 |
|
|
2021
Q2 | $1.31M | Buy |
37,522
+1,698
| +5% | +$59.5K | 0.01% | 1331 |
|
|
2021
Q1 | $1.46M | Sell |
35,824
-3,374
| -9% | -$138K | 0.01% | 1196 |
|
|
2020
Q4 | $1.7M | Sell |
39,198
-3,642
| -9% | -$158K | 0.01% | 1051 |
|
|
2020
Q3 | $2.36M | Sell |
42,840
-7,274
| -15% | -$401K | 0.02% | 815 |
|
|
2020
Q2 | $3.16M | Buy |
50,114
+11,481
| +30% | +$725K | 0.02% | 699 |
|
|
2020
Q1 | $1.97M | Sell |
38,633
-8,484
| -18% | -$434K | 0.02% | 793 |
|
|
2019
Q4 | $3.75M | Buy |
47,117
+278
| +0.6% | +$22.1K | 0.03% | 765 |
|
|
2019
Q3 | $2.27M | Buy |
46,839
+43
| +0.1% | +$2.09K | 0.02% | 958 |
|
|
2019
Q2 | $2.46M | Sell |
46,796
-11,309
| -19% | -$595K | 0.02% | 963 |
|
|
2019
Q1 | $3.08M | Sell |
58,105
-5,363
| -8% | -$284K | 0.03% | 878 |
|
|
2018
Q4 | $2.61M | Sell |
63,468
-2,609
| -4% | -$107K | 0.02% | 910 |
|
|
2018
Q3 | $2.51M | Buy |
66,077
+2,506
| +4% | +$95.2K | 0.02% | 1111 |
|
|
2018
Q2 | $2.87M | Buy |
63,571
+6,850
| +12% | +$310K | 0.02% | 1030 |
|
|
2018
Q1 | $2.74M | Sell |
56,721
-1,878
| -3% | -$90.7K | 0.01% | 1408 |
|
|
2017
Q4 | $2.31M | Sell |
58,599
-43,886
| -43% | -$1.73M | 0.01% | 1556 |
|
|
2017
Q3 | $3.18M | Buy |
102,485
+54,938
| +116% | +$1.71M | 0.01% | 1327 |
|
|
2017
Q2 | $1.3M | Buy |
+47,547
| New | +$1.3M | ﹤0.01% | 1913 |
|